We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Novel Biotherapeutics for the Treatment of Cancer

Article   Mar 16, 2018 | by Joanna Owens, PhD, Freelance Writer and Editor, UK

 
Novel Biotherapeutics for the Treatment of Cancer

T-cells and cancer cell

 
 
 

RELATED ARTICLES

Superantigens – The Immune System Meets Microbes

Article

Our immune system is fine-tuned to respond to a variety of different antigens, but some pathogens have found a way to hijack the immune system using superantigens. But how do superantigens manipulate the immune system into causing such extreme reactions? And what other secrets do they hide?

READ MORE

Augmented Intelligence: the 'Other AI' That's Key to Delivering the Lab of the Future

Article

In this exclusive article, Dr Peter Crane, corporate strategy manager at Synthace, explains why augmented and assistive technologies could enhance the scientist and provide the first step towards a data science-led future for biopharma.

READ MORE

"MOSAIC" HIV Vaccine to be Tested in Thousands Globally

Article

A clinical trial testing a "mosaic" HIV vaccine is due to commence in September. The trial is pertinent considering a recent UNAIDS report expressed concerns that the pace of progress in reducing new HIV infections has slowed. This article discusses the plans for the trial and the current status of vaccine research in the field.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE